Free Trial

Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume

Enveric Biosciences logo
$1.31 -0.01 (-0.76%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$1.28 -0.03 (-2.29%)
As of 07/25/2025 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enveric Biosciences Short Interest Data

Enveric Biosciences (ENVB) has a short interest of 269,000 shares, representing 12.57% of the float (the number of shares available for trading by the public). This marks a 17.78% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 192,885 shares to cover all short positions.

Current Short Interest
269,000 shares
Previous Short Interest
228,400 shares
Change Vs. Previous Month
+17.78%
Dollar Volume Sold Short
$325.49 thousand
Short Interest Ratio
1.3 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
2,472,000 shares
Float Size
2,140,000 shares
Short Percent of Float
12.57%
Today's Trading Volume
82,840 shares
Average Trading Volume
192,885 shares
Today's Volume Vs. Average
43%
Short Selling Enveric Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ENVB Short Interest Over Time

ENVB Days to Cover Over Time

ENVB Percentage of Float Shorted Over Time

Enveric Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2025269,000 shares $325.49 thousand +17.8%12.6%1.3 $1.21
6/15/2025228,400 shares $276.36 thousand -25.0%10.7%1.1 $1.21
5/31/2025304,600 shares $356.41 thousand +143.3%14.2%1.5 $1.17
5/15/2025125,200 shares $157.75 thousand -27.2%5.9%0 $1.26
4/30/2025172,000 shares $227.04 thousand -1.3%7.0%0.1 $1.32
4/15/2025174,200 shares $216.48 thousand -3.0%7.5%0.1 $1.24
3/31/2025179,500 shares $249.51 thousand -25.6%7.7%0.1 $1.39
3/15/2025241,100 shares $417.10 thousand -80.6%13.3%0.1 $1.73
2/28/20251,240,000 shares $3.47 million +351.4%77.5%0.5 $2.80
2/15/2025274,700 shares $439.52 thousand +17.8%15.2%0.1 $1.60
1/31/2025233,200 shares $487.39 thousand -42.8%16.9%1.5 $2.09
1/15/2025407,400 shares $145.44 thousand +498.2%4.3%0.8 $0.36
12/31/202468,100 shares $24.41 thousand -56.7%0.7%0.1 $0.36
12/15/2024157,200 shares $57.14 thousand +36.1%1.7%0.3 $0.36
11/30/2024115,500 shares $38.12 thousand -57.6%1.2%0.2 $0.33
11/15/2024272,200 shares $100.71 thousand -17.6%3.0%0.5 $0.37
10/31/2024330,200 shares $164.84 thousand +70.9%4.1%0.7 $0.50
10/15/2024193,200 shares $81.72 thousand -2.9%2.4%0.1 $0.42
9/30/2024199,000 shares $94.33 thousand -2.8%2.3%0.2 $0.47
9/15/2024204,700 shares $102.55 thousand -38.3%2.3%0.2 $0.50
8/31/2024332,000 shares $168.46 thousand -29.2%3.8%0.3 $0.51
8/15/2024469,100 shares $226.58 thousand -80.9%5.3%0.4 $0.48
7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47
7/15/2024131,700 shares $71.38 thousand -13.4%1.7%0.2 $0.54
6/30/2024152,100 shares $95.25 thousand -43.4%2.0%0.3 $0.63
6/15/2024268,800 shares $198.91 thousand -20.5%3.5%0.5 $0.74
5/31/2024338,100 shares $263.72 thousand -50.2%4.5%0.2 $0.78
5/15/2024678,900 shares $534.97 thousand +736.1%8.9%0.1 $0.79
4/30/202481,200 shares $76.33 thousand -15.1%1.1%0 $0.94
4/15/202495,600 shares $88.10 thousand -62.5%1.4%0 $0.92
3/31/2024254,900 shares $254.90 thousand +69.5%4.2%0.1 $1.00
3/15/2024150,400 shares $162.43 thousand +58.2%3.2%0 $1.08
2/29/202495,100 shares $137.90 thousand +47.0%4.2%0 $1.45
2/15/202464,700 shares $54.28 thousand +181.3%2.5%0.2 $0.84
1/31/202423,000 shares $16.93 thousand -58.6%0.9%0.2 $0.74
1/15/202455,600 shares $71.17 thousand +334.4%2.3%1.4 $1.28
12/31/202312,800 shares $16.64 thousand +6.7%0.6%0.4 $1.30
12/15/202312,000 shares $16.08 thousand +263.6%0.6%0.7 $1.34
11/30/20233,300 shares $4.88 thousand -54.8%0.2%0.2 $1.48
11/15/20237,300 shares $10.40 thousand -62.4%0.4%0.4 $1.43
Elon Musk: “This will transform civilization as we know it.” (Ad)

Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.

Click here to see the robot stock that could dominate this revolution
10/31/202319,400 shares $33.37 thousand -19.5%1.0%0.9 $1.72
10/15/202324,100 shares $50.85 thousand +121.1%1.3%0.3 $2.11
9/30/202310,900 shares $25.94 thousand -55.0%0.6%0.1 $2.38
9/15/202324,200 shares $55.18 thousand -45.3%1.2%0.3 $2.28
8/31/202344,200 shares $95.47 thousand -42.3%2.3%0.4 $2.16
8/15/202376,600 shares $182.31 thousand +86.4%4.0%0.1 $2.38
7/31/202341,100 shares $109.74 thousand +95.7%2.2%0 $2.67
7/15/202321,000 shares $60.27 thousand -43.1%1.1%0 $2.87
6/30/202336,900 shares $124.35 thousand -65.6%2.0%0 $3.37
6/15/2023107,400 shares $414.56 thousand -69.1%5.8%0 $3.86
5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19
5/15/202322,700 shares $34.05 thousand -30.2%1.2%0 $1.50
4/30/202332,500 shares $59.52 thousand +44.4%1.8%1 $1.83
4/15/202322,500 shares $34.20 thousand +39.8%1.2%0.6 $1.52
3/31/202316,100 shares $26.79 thousand +64.3%0.9%0.6 $1.66
3/15/20239,800 shares $16.95 thousand +71.9%0.6%0.3 $1.73
2/28/20235,700 shares $11.91 thousand -38.0%0.3%0.1 $2.09
2/15/20239,200 shares $24.93 thousand -37.8%0.5%0.2 $2.71
1/31/202314,800 shares $42.48 thousand -53.6%0.8%0.3 $2.87
1/15/202331,900 shares $90.28 thousand -21.2%1.7%0.7 $2.83
12/30/202240,500 shares $84.24 thousand -11.2%2.0%0.7 $2.08
12/15/202245,600 shares $97.58 thousand +27.4%2.3%0.9 $2.14
11/30/202235,800 shares $102.75 thousand -17.5%1.8%0.5 $2.87
11/15/202243,400 shares $147.56 thousand -37.7%2.2%0.4 $3.40
10/31/202269,700 shares $237.68 thousand +36.1%4.7%0.3 $3.41
10/15/202251,200 shares $175.10 thousand +55.2%3.6%0.1 $3.42
9/30/202233,000 shares $139.26 thousand -60.1%2.3%0.1 $4.22
9/15/202282,800 shares $477.76 thousand +11.7%5.8%0.2 $5.77
8/31/202274,100 shares $413.48 thousand -21.7%5.4%0.2 $5.58
8/15/202294,600 shares $624.36 thousand -43.4%6.9%0.2 $6.60
7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40
7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00
6/30/20222,360,000 shares $505.75 thousand -23.9%N/A0.9 $0.21
6/15/20223,100,000 shares $651 thousand -4.6%N/A1.6 $0.21
5/31/20223,250,000 shares $642.53 thousand -2.1%N/A1.5 $0.20
5/15/20223,320,000 shares $664 thousand -2.4%N/A1.1 $0.20
4/30/20223,400,000 shares $918.34 thousand +165.6%N/A1 $0.27
4/15/20221,280,000 shares $384.38 thousand -19.5%N/A0.4 $0.30
3/31/20221,590,000 shares $524.70 thousand -17.6%N/A0.6 $0.33
3/15/20221,930,000 shares $536.54 thousand +498.1%N/A0.8 $0.28
2/28/2022322,700 shares $88.58 thousand -67.6%N/A0.1 $0.27
2/15/2022996,300 shares $313.83 thousand +421.9%N/A0.8 $0.32
1/31/2022190,900 shares $121.47 thousand -67.1%N/A0.3 $0.64
1/15/2022580,200 shares $434.45 thousand +143.0%N/A0 $0.75
12/31/2021238,800 shares $222.08 thousand -41.9%N/A0.3 $0.93
12/15/2021411,300 shares $435.98 thousand -50.8%N/A0.3 $1.06
11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30
11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80
10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76
10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89
Elon Musk: “This will transform civilization as we know it.” (Ad)

Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by 2025, robots will shift from novelty to necessity — disrupting nearly every industry in their path. But one overlooked sector could become the real winner… and one little-known company may be the best way to get ahead of the boom.

Click here to see the robot stock that could dominate this revolution
9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07
9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65
8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99
8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72
7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91
7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06
6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38
6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21
5/28/20211,060,000 shares $2.36 million +183.1%6.5%0.4 $2.23
5/14/2021374,400 shares $711.36 thousand -30.3%2.3%0.1 $1.90
4/30/2021536,900 shares $1.33 million -41.1%3.4%0.1 $2.48
4/15/2021911,800 shares $2.28 million +17.5%5.7%0.1 $2.50
3/31/2021776,000 shares $2.30 million +34.6%5.6%0.1 $2.97
3/15/2021576,400 shares $2.13 million +233.8%4.1%0.1 $3.70
2/26/2021172,700 shares $628.63 thousand -9.4%2.0%0.1 $3.64
2/12/2021190,700 shares $928.71 thousand +110.0%2.2%0.1 $4.87
1/29/202190,800 shares $345.95 thousand -42.4%10.0%0.1 $3.81
1/15/2021157,700 shares $657.61 thousand No Change17.4%0.2 $4.17

ENVB Short Interest - Frequently Asked Questions

What is Enveric Biosciences' current short interest?

Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 269,000 shares of ENVB short. 12.57% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest.

What is a good short interest ratio for Enveric Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 1.0. Learn More on Enveric Biosciences's short interest ratio.

What is a good short interest percentage for Enveric Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.57% of Enveric Biosciences' floating shares are currently sold short.

Is Enveric Biosciences' short interest increasing or decreasing?

Enveric Biosciences saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 269,000 shares, an increase of 17.8% from the previous total of 228,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Enveric Biosciences' float size?

Enveric Biosciences currently has issued a total of 2,470,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 2,140,000 shares.

How does Enveric Biosciences' short interest compare to its competitors?

12.57% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Enveric Biosciences: Equillium, Inc. (8.82%), BioCardia, Inc. (0.54%), Synaptogenix, Inc. (12.63%), Minerva Neurosciences, Inc (0.50%), BioVie Inc. (7.52%), AlloVir, Inc. (2.56%), BioXcel Therapeutics, Inc. (6.08%), Ainos, Inc. (4.92%), Brainstorm Cell Therapeutics Inc. (7.91%), Phio Pharmaceuticals Corp. (7.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Enveric Biosciences stock?

Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Enveric Biosciences?

A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further.

How often is Enveric Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:ENVB) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners